Periplasmic cold expression and one-step purification of human dihydrolipoamide dehydrogenase

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Dihydrolipoamide dehydrogenase (LADH) is a FAD-linked subunit of α-ketoglutarate, pyruvate and branched-chain amino acid dehydrogenases and the glycine cleavage system. As an oxidoreductase it transfers electrons from the dihydrolipoic acid prosthetic group to the NAD+ cofactor via its FAD center. Besides its physiological function it is capable of generating harmful reactive oxygen species (ROS) in pathological settings therefore it is implicated in neurodegeneration, ischemia-reperfusion, cancer and several other disorders. Pathological mutants of the enzyme cause severe, sometimes lethal syndromes like hypotonia, metabolic acidosis or inefficiency in development. Recently it has been revealed that LADH is a moonlighting protease when specific mutations in the dimerization surface destabilize the functional homodimer and expose a serine-protease-like catalytic dyad. As the basis of versatile functions of LADH is far from elucidation, there is a constant need for a pure and functional enzyme product for investigations. Several studies used recombinant human LADH before, however, it was generated by more complicated and/or physiologically less compatible protocols than reported here; most papers on functional and structural studies do not even report detailed protocols and characteristics (most importantly the purity) of their protein products. Here we describe the details of an optimized, easy-to-use periplasmic expression and one-step purification protocol for obtaining a highly pure, active and authentic (tag-cleaved) enzyme with the characterization of the protein product. The purified LADH can be used in biophysical and structural studies while the published protocol is easily convertible to a protein labeling procedure.

Original languageEnglish
Pages (from-to)50-57
Number of pages8
JournalProtein Expression and Purification
Volume63
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Dihydrolipoamide Dehydrogenase
Flavin-Adenine Dinucleotide
Oxidoreductases
Enzymes
Branched Chain Amino Acids
Proteins
Muscle Hypotonia
Dimerization
Serine Proteases
Acidosis
Pyruvic Acid
NAD
Reperfusion
Reactive Oxygen Species
Peptide Hydrolases
Ischemia
Electrons
Mutation
Neoplasms

Keywords

  • α-Ketoglutarate dehydrogenase
  • Dihydrolipoamide dehydrogenase
  • Escherichia coli
  • LADH
  • Periplasmic expression
  • Strep-tag

ASJC Scopus subject areas

  • Biotechnology

Cite this

@article{2dd901b45e7949f2ac834db019997617,
title = "Periplasmic cold expression and one-step purification of human dihydrolipoamide dehydrogenase",
abstract = "Dihydrolipoamide dehydrogenase (LADH) is a FAD-linked subunit of α-ketoglutarate, pyruvate and branched-chain amino acid dehydrogenases and the glycine cleavage system. As an oxidoreductase it transfers electrons from the dihydrolipoic acid prosthetic group to the NAD+ cofactor via its FAD center. Besides its physiological function it is capable of generating harmful reactive oxygen species (ROS) in pathological settings therefore it is implicated in neurodegeneration, ischemia-reperfusion, cancer and several other disorders. Pathological mutants of the enzyme cause severe, sometimes lethal syndromes like hypotonia, metabolic acidosis or inefficiency in development. Recently it has been revealed that LADH is a moonlighting protease when specific mutations in the dimerization surface destabilize the functional homodimer and expose a serine-protease-like catalytic dyad. As the basis of versatile functions of LADH is far from elucidation, there is a constant need for a pure and functional enzyme product for investigations. Several studies used recombinant human LADH before, however, it was generated by more complicated and/or physiologically less compatible protocols than reported here; most papers on functional and structural studies do not even report detailed protocols and characteristics (most importantly the purity) of their protein products. Here we describe the details of an optimized, easy-to-use periplasmic expression and one-step purification protocol for obtaining a highly pure, active and authentic (tag-cleaved) enzyme with the characterization of the protein product. The purified LADH can be used in biophysical and structural studies while the published protocol is easily convertible to a protein labeling procedure.",
keywords = "α-Ketoglutarate dehydrogenase, Dihydrolipoamide dehydrogenase, Escherichia coli, LADH, Periplasmic expression, Strep-tag",
author = "A. Ambrus and B. T{\"o}rőcsik and V. {\'A}d{\'a}m-Vizi",
year = "2009",
month = "1",
doi = "10.1016/j.pep.2008.09.009",
language = "English",
volume = "63",
pages = "50--57",
journal = "Protein Expression and Purification",
issn = "1046-5928",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Periplasmic cold expression and one-step purification of human dihydrolipoamide dehydrogenase

AU - Ambrus, A.

AU - Törőcsik, B.

AU - Ádám-Vizi, V.

PY - 2009/1

Y1 - 2009/1

N2 - Dihydrolipoamide dehydrogenase (LADH) is a FAD-linked subunit of α-ketoglutarate, pyruvate and branched-chain amino acid dehydrogenases and the glycine cleavage system. As an oxidoreductase it transfers electrons from the dihydrolipoic acid prosthetic group to the NAD+ cofactor via its FAD center. Besides its physiological function it is capable of generating harmful reactive oxygen species (ROS) in pathological settings therefore it is implicated in neurodegeneration, ischemia-reperfusion, cancer and several other disorders. Pathological mutants of the enzyme cause severe, sometimes lethal syndromes like hypotonia, metabolic acidosis or inefficiency in development. Recently it has been revealed that LADH is a moonlighting protease when specific mutations in the dimerization surface destabilize the functional homodimer and expose a serine-protease-like catalytic dyad. As the basis of versatile functions of LADH is far from elucidation, there is a constant need for a pure and functional enzyme product for investigations. Several studies used recombinant human LADH before, however, it was generated by more complicated and/or physiologically less compatible protocols than reported here; most papers on functional and structural studies do not even report detailed protocols and characteristics (most importantly the purity) of their protein products. Here we describe the details of an optimized, easy-to-use periplasmic expression and one-step purification protocol for obtaining a highly pure, active and authentic (tag-cleaved) enzyme with the characterization of the protein product. The purified LADH can be used in biophysical and structural studies while the published protocol is easily convertible to a protein labeling procedure.

AB - Dihydrolipoamide dehydrogenase (LADH) is a FAD-linked subunit of α-ketoglutarate, pyruvate and branched-chain amino acid dehydrogenases and the glycine cleavage system. As an oxidoreductase it transfers electrons from the dihydrolipoic acid prosthetic group to the NAD+ cofactor via its FAD center. Besides its physiological function it is capable of generating harmful reactive oxygen species (ROS) in pathological settings therefore it is implicated in neurodegeneration, ischemia-reperfusion, cancer and several other disorders. Pathological mutants of the enzyme cause severe, sometimes lethal syndromes like hypotonia, metabolic acidosis or inefficiency in development. Recently it has been revealed that LADH is a moonlighting protease when specific mutations in the dimerization surface destabilize the functional homodimer and expose a serine-protease-like catalytic dyad. As the basis of versatile functions of LADH is far from elucidation, there is a constant need for a pure and functional enzyme product for investigations. Several studies used recombinant human LADH before, however, it was generated by more complicated and/or physiologically less compatible protocols than reported here; most papers on functional and structural studies do not even report detailed protocols and characteristics (most importantly the purity) of their protein products. Here we describe the details of an optimized, easy-to-use periplasmic expression and one-step purification protocol for obtaining a highly pure, active and authentic (tag-cleaved) enzyme with the characterization of the protein product. The purified LADH can be used in biophysical and structural studies while the published protocol is easily convertible to a protein labeling procedure.

KW - α-Ketoglutarate dehydrogenase

KW - Dihydrolipoamide dehydrogenase

KW - Escherichia coli

KW - LADH

KW - Periplasmic expression

KW - Strep-tag

UR - http://www.scopus.com/inward/record.url?scp=54949157495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54949157495&partnerID=8YFLogxK

U2 - 10.1016/j.pep.2008.09.009

DO - 10.1016/j.pep.2008.09.009

M3 - Article

C2 - 18845259

AN - SCOPUS:54949157495

VL - 63

SP - 50

EP - 57

JO - Protein Expression and Purification

JF - Protein Expression and Purification

SN - 1046-5928

IS - 1

ER -